Kane Biotech Inc. (KNBIF) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Winnipeg, MB, Canada. The current CEO is Robert Huizinga.
KNBIF has IPO date of 2007-08-07, listed on the Other OTC, a market capitalization of $3.55M.
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops pet oral care products under the StrixNB and bluestem brands; animal and human wound care solutions under the DispersinB name; shampoos for dogs, cats, and horses under the Alosera name; and medical device coatings under the Aledex name. It also offers scalp care products under the DermaKB brand name, wound care products under the Coactiv+ brand name, as well as other products under the goldstem, silkstem, and DermaKB Biofilm brand names. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
